At a glance
- Originator Organon
- Class Antidepressants; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor antagonists; Biogenic monoamine uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 20 Feb 1997 New profile
- 20 Feb 1997 Discontinued-I for Depression in Netherlands (Unknown route)